Suggestions
Elyssa Benedikt
Global Rare Disease Value & Access at Sanofi Genzyme
Elyssa Benedikt is currently the Global Rare Disease Value & Access lead at Sanofi Genzyme, where she plays a significant role in the commercialization of rare disease therapies. Her work includes leading four ophthalmology programs, which encompass three gene therapies targeting rare ocular diseases that are in Phase I/II clinical trials. She is based in the Greater Boston area and has a background that includes education from Dartmouth College.12
Highlights
Jan 20 · clevelandjewishnews.com
Campbell-Benedikt | Weddings | clevelandjewishnews.com